InvestorsHub Logo
Followers 265
Posts 8908
Boards Moderated 2
Alias Born 02/02/2012

Re: BBstocks77 post# 186476

Wednesday, 04/01/2020 2:41:22 PM

Wednesday, April 01, 2020 2:41:22 PM

Post# of 205095
MASSIVE ARYC COVID-19 NEWS - Email update at bottom.

President Trump's team: “We really want a fingerpick type assay”



https://media.discordapp.net/attachments/684631519259656232/691802593831288903/video0.mov

ARRAYIT CoronaVirus Test Approved!!


http://www.arrayit.com/SARS-CoV-2COVID-19TestInstructions.pdf

Order the COVID-19 Test now! covid-19@arrayit.com


https://www.arrayit.com/


The science behind how Arrayit tests for COVID-19 among others - thanks for sharing.

Sensors (Basel). 2017 Sep; 17(9): 2157.
Published online 2017 Sep 20. doi: 10.3390/s17092157
PMCID: PMC5621023
PMID: 28930175
Sensitive Genotyping of Foodborne-Associated Human Noroviruses and Hepatitis A Virus Using an Array-Based Platform
Beatriz Quiñones,1,* Bertram G. Lee,1 Todd J. Martinsky,2 Jaszemyn C. Yambao,1 Paul K. Haje,2 and Mark Schena2

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621023/

Arrayit is now a Medicare in-network provider. Offering one-of-a-kind Allergy Testing that's fast, convenient and most importantly, billable. Review the data that supports this success, and leverage this success for your own clinic.”

https://www.patientdatasolutions.com/medicare.jsp

Centers for Medicare & Medicaid Services:

https://www.cms.gov/apps/clia/clia_start.asp?CLIANum=05D2147467&LabName=&GeoCity=&state=AK&GeoZip=&appType=%25&isSubmitted=clia2

https://npiregistry.cms.hhs.gov/registry/provider-view/1104316157

Arrayit Corporation Approved as New Medicare Part B Healthcare Provider for Allergy Testing Services

https://www.globenewswire.com/news-release/2019/08/12/1900293/0/en/Arrayit-Corporation-Approved-as-New-Medicare-Part-B-Healthcare-Provider-for-Allergy-Testing-Services.html

Extra on Arrayit:
Arrayit recently completed an allergy testing pilot program for a top retail chain, established a nationwide network of 1,700 allergy sales professionals, met with top officials at the United States Food and Drug Administration (FDA) regarding approval of a major product line, fulfilled an FDA clinical instrumentation contract, received approval for in-store promotions by a major retailer, announced allergy testing partnerships with major allergy therapeutics providers, received approval for direct Medicare billing and electronic Medicare reimbursement from the Centers for Medicare and Medicaid Services, launched the Patient Data Solutions allergy portal for doctors and clinics, celebrated 25 years of company operations, announced an allergy testing services agreement with a major health and wellness provider, provided a letter to shareholders from the company's Chief Executive Officer, received endorsement by First Pediatrics Medical Group, announced in-network allergy testing services contracting with a top five commercial health benefits company, doubled its weekly billing guidance to $2 million per week, appointed an Apple enterprise healthcare partner to accelerate revenues and earnings growth, expanded allergy testing services evaluation with a major retail pharmacy chain, grew its allergy testing healthcare network to more than 700 clinics, retained a top credentialing company to accelerate commercial and government payor reimbursement, aced five consecutive rounds of proficiency testing with a top proficiency testing leader, signed an in-network allergy testing services agreement with a major California-based health benefits company, received a certificate of deemed status into 2020 from the California Department of Public Health and expanded its clinic network in Hawaii. Philippines test revenues and earnings will be reported in the company's upcoming audited quarterly and annual financial statements.

CEO Rene Schena states, "Global expansion of our health and wellness testing services in the Philippines is in keeping with our mission to make healthcare more accessible internationally. With universal healthcare coverage and a rising standard of living, the Philippines offers a tremendous growth opportunity for Arrayit and its shareholders as we expand into Southeast Asia and points beyond."
https://www.marketwatch.com/press-release/arrayit-corporation-announces-global-expansion-of-finger-stick-health-and-wellness-testing-services-2019-07-29-61841734?siteid=bigcharts&dist=bigcharts




ALL i say is my opinion only.